► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />Bayer is planning to demerge its material science business and focus on life sciences. Lex's Oliver Ralph and Robert Armstrong discuss whether the spreadsheet logic of the split makes real business sense.<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br />Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k<br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
